Vitamin D3 receptor (VDR) expression in HC-11 mammary cells: Regulation by growth-modulatory agents, differentiation, and Ha-ras transformation

Breast Cancer Research and Treatment

Volumn 54, Issue 2, 1999, Pages 123-134

  Escaleira, Maria Teresa F ^a   Brentani, M Mitzi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cell proliferation; Ha ras transformation; HC 11 mammary cells; Mammary differentiation; VDR mRNA modulation; Vitamin D3

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA CASEIN; COLECALCIFEROL; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; PROLACTIN; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; DEXAMETHASONE; GROWTH PROMOTOR; INSULIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DESENSITIZATION; FLOW CYTOMETRY; GROWTH REGULATION; HORMONE ACTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE H RAS; PREGNANCY; PRIORITY JOURNAL; RECEPTOR GENE; RECEPTOR UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL CYCLE; CELL LINE; CYTOLOGY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; ONCOGENE RAS; PHYSIOLOGY; UDDER;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION; GENES, RAS; GROWTH SUBSTANCES; INSULIN; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED BALB C; PREGNANCY; PROLACTIN; RECEPTORS, CALCITRIOL; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032589168     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006198107805     Document Type: Article

References (61)

1. 3 modulation of mammary tumor cell growth in vivo and in vitro. Breast Cancer Res Treat 27: 69-81, 1993
2. 3. Cancer Res 47: 21-25, 1987
3. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SRT: Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191-202, 1994
4. Sludzinski GP, Moore DC: Sunlight - can it prevent as well as cause cancer? Cancer Res 55: 4014-4022, 1995
5. 5. J Natl Cancer Inst 89: 212-218, 1997
6. 3: a novel class inhibitors of proliferation of human breast cancer cell lines. Cancer Res 57: 4545-4550, 1997
7. 3 on the morphology of human breast cancer cell line BT-20. Differentiation 40: 63-69, 1989
8. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of proliferation and differentiation of human breast cancer cell lines. Cancer Res 55: 2822-2830, 1995
9. Vanweelden K, Welsh J: The vitamin D analog EB1099 induces regression of MCF-7 xenografts in nude mice. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D-Chemistry, Biology and Clinical Applications of the Steroid Hormone. W. de Gruyter, Berlin, 1997, pp 417-418
10. MacDonald PN, Dowd DR, Haussler MR: New insight into the structure and functions of the vitamin D receptor. Sem Nephrol 14: 101-118, 1994
11. Hewison M, Dabrowski M, Faulkner L, Hughson E, Vadher S, Rut A, Brickell PM, O'Riordan JLH, Katz DR: Transfection of vitamin D receptor cDNA into the monoblastoid cell line U937. J Immunol 153: 5709-5719, 1994
12. 3 are mediated exclusively through the genomic signaling pathway. Endocrinology 137: 1554-1561, 1996
13. 3 receptor in T47D breast cancer cells. J Steroid Biochem Mol Biol 45: 257-263, 1993
14. 3 receptors in breast cancer cells. Lancet ii: 1335-1336, 1979
15. 3 receptors in established human cancer cell lines in culture. Cancer Res 42: 1116-1119, 1982
16. 3 in intact human cancer cells. Endocrinology 116: 971-977, 1985
17. 3 receptors by vitamin D analogs in cultured mammalian cells. Endocrinology, 117: 2203-2210, 1985
18. 3 receptors in breast cancer and their relationship to biochemical and clinical indices. Cancer Res 44: 1677-1681, 1984
19. Colston KW, Berger U, Coombes RC: Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet i: 188-191, 1989
20. 3 receptor in breast cancer and relationship to prognosis. Cancer Res 51: 239-244, 1991
21. 3 receptor in primary breast cancer. Cancer Res 46: 5406-5408, 1986
22. Mezzetti G, Barbiroli B, Oka T: 1,25-dihydroxycholecalciferol receptor in hormonally induced differentiation of mouse mammary gland in culture. Endocrinology 120: 2488-2493, 1987
23. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B: Prolactin regulation of beta-casein gene expression and of a cystosolic 120-kDa protein in a cloned mammary epithelical cell line. Embo J 7: 2089-2095, 1988
24. Venesio T, Taverna D, Hynes NE, Deed R, MacAllan D, Ciardiello F, Valverius EM, Salomon DS, Callahan R, Merlo G: The int-2 gene product acts as a growth factor and substitutes for basic fibroblast growth factor in promoting the differentiation of a normal mouse mammary epithelial cell line. Cell Growth Differ 3: 63-71, 1992
25. Happ B, Hynes NE, Groner B: Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with lactogenic hormone-dependent activation of the mammary gland specific transcription factor. Cell Growth Differ 4: 9-15, 1993
26. Taverna D, Groner B, Hynes N: Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differ 2: 145-154, 1991
27. Chomczinski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-536, 1993
28. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning - A Laboratory Manual. Cold Spring Harbor Lab, Plainview. NY, 1989
29. 3 receptor. Proc Natl Acad Sci USA 85: 9499-9502, 1988
30. Hobbs AA, Richards DA, Kessler DS, Rosen JM: Complex hormonal regulation of rat casein gene expression. J Biol Chem 157: 3598-3605, 1982
31. Misrahi M, Atger M, D'Auriol L, Loosefelt H, Meriel C, Fridlansky F, Guiochon-Mantel A, Galibert F, Milgrom E: Complete amino acid sequence of the human progesterone receptor deduced from cloned cDNA. Biochem Biophys Res Commun 143: 740-748, 1987
32. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (London) 320: 134-139, 1986
33. Arnheim N: Characterization of mouse ribosomal gene fragments purified by molecular cloning. Gene 7: 83-96, 1979
34. Wingren S, Stål O, Nordenskjökl B: Flow cytometric analysis of S-phase fraction in breast carcinoma using gating un cells containing cytokeratin. Br J Cancer 69: 546-549, 1994
35. 3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 58: 395-401, 1996
36. 3 on cell-cycle kinetics of T 47D human breast cancer cells. J Cell Physiol 138: 611-616, 1989
37. 3-resistant MCF-7 cell line. Endocrinology 137: 400-409, 1996
38. 3 and its analogue, EB1089, in human breast cancer cells. Oncogene 15: 1555-1563, 1997
39. Hall RE, Lee CSL, Alexander IE, Shine J, Clarke CL, Sutherland RL: Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 46: 1081-1087, 1990
40. 3 receptors in human breast cancer cell lines. Cancer Res 40: 4764-4767, 1980
41. 3 receptor (VDR) and retinoic-X receptor-α (RXR-α) in breast cancer. In: Norman AW, Bouillon R, Thomasset M (eds) Vitmin D-Chemistry, Biology and Clinical Applications of the Steroid Hormone. W. der Gruyter, Berlin, 1997, pp 475-476
42. 3 in a keratinocyte model of tumor progression. J Biol Chem 267: 12162-12167, 1992
43. Martins VR, Brentani MM, Housley PR: Attenuation of glucocorticoid receptor by the Ha-ras oncogene. Endocrine 3: 305-312, 1995
44. Darwiche N, Scita G, Jones C, Rutherg S, Greenwald E, Tennenbaum T, Collins SJ, De Luca LM, Yuspa SH: Loss of retinoic acid receptors in mouse skin tumors in associated with activation of the Ha-ras oncogene and high risk for premalignant progression. Cancer Res 56: 4942-4949, 1996
45. 3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 38: 395-401, 1996
46. 3-derivatives and breast tumor cell growth: effect on intracellular calcium and apoptosis. Int J Cancer 61: 806-811, 1995
47. 3 induces morphological and biochemical markers of apotosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 58: 367-376, 1996
48. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE: p53-dependent and p53-independent activation of apotosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 128: 1185-1196, 1995
49. Merlo GR, Venesio T, Taverna D, Marte BM, Callahan R, Hynes NE: Growth suppression of normal mammary epithelial cells by wild type p53. Oncogene 9: 443-453, 1994
50. 3 is accompanied by induction of apolipoprotein D expression. Cancer Res 57: 4091-4097, 1997
51. 3 in T-47D human breast cancer cells. J Steroid Biochem Mol Biol 54: 147-153, 1995
52. Folgueira MAAK, Federico MHH, Katayama MLH, Silva MRP, Brentani MM: Expression of vitamin D receptor (VDR) in HL-60 cells is differentially regulated during the process of differentiation induced by phorbol ester, retinoic acid or interferon-γ. J Steroid Biochem Mol Biol 66 (in press)
53. 3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 90(2): 134-141, 1998
54. Hulla W, Kállay E, Krugluger W, Peterlik M, Cross HS: Growth control of human colon-adenocarcinoma-derived CACO-2 cells by vitamin D compounds and extracellular calcium in vitro: relation to c-myc oncogene and vitamin-D-receptor expression. Int J Cancer 62: 711-716, 1995
55. Zhao X, Feldman D: Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-20 human colon cancer cells. Endocrinology 132: 1808-1814, 1993
56. Cross HS, Hulla W, Tong WM, Peterlik M: Growth regulation of human colon adenocarcinoma-derived cells by calcium and epidermal growth factor. J Nutr 125: P2004S-2008S, 1995
57. Donepudi M, Welsh JE: EGF down-regulates both calbindin D-28K and the VDR in MDBK cells. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D - A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. W. de Gruyter, Berlin, 1994, pp 411-412
58. 3 receptor expression in cultured cells by serum and growth factors. J Bone Miner Res 6: 1099-1107, 1991
59. 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes. J Invest Dermatol. 104: 113-117, 1995
60. Salomon DS, Perroteau I, Kidwell WR: Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha transforming growth factors in ras-transformed mouse mammary epithelial cells. J Cell Physiol 130: 397-406, 1987
61. Thor A, Ohuchi N, Horan Hand P, Callahan R, Weeks MO, Theillet C, Lidereau R, Escot C, Page DL, Vilasi V, Schlom J: Ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues. Lab Invest 55: 603-615, 1986